The US Army handed out its first-ever microreactor deployment contract on August 26, and BWX Technologies won it. The stock did not celebrate. Shares traded around $153 to $157 two days later, more than a third below their 52-week high of $241.82, even as the company’s reactor design became the first of five competing technologies picked for a real military installation.
BWXT Wins Army’s First Microreactor Contract at Fort Campbell
The US Army announced on August 26 that it had selected five companies to build and operate nuclear microreactors at five bases under its Janus Program, a milestone-based contracting vehicle that could pay out up to $2.2 billion across all five awards combined, not to any single company alone. BWXT Advanced Technologies, a subsidiary of BWX Technologies, Inc. (NYSE: BWXT), was selected to deploy a single 20-megawatt BWXT Advanced Nuclear Reactor (BANR) at Fort Campbell, Kentucky, the first of the five Janus awards to reach a specific base. The reactor’s footprint is expected to be under 5 acres. Site characterization, licensing, and design work are slated to begin immediately, with construction targeted for late 2028 and the reactor expected to be operational in the early 2030s.
BWXT arrives at this contract with existing momentum in the space. The company supplied TRISO nuclear fuel (a coated-particle fuel form designed to withstand higher temperatures and reduce meltdown risk compared to conventional fuel rods) that powered a competing Janus vendor, Antares Nuclear’s Mark-0 demonstration reactor, to first criticality at Idaho National Laboratory earlier this year under the Department of Energy’s Reactor Pilot Program, the first advanced reactor criticality achieved by a private company under that initiative. On the commercial side, Tata Chemicals Soda Ash LLC has signed a non-binding letter of intent to explore deploying up to eight BANR units; that is an early exploratory step, not a signed order, and should not be read as committed revenue.
The stock’s reaction has been muted at best. As of August 28, shares were down 20.4% over the trailing 90 days, and by August 29 were trading in the mid-$150s against a 52-week range of $147.74 to $241.82. The company’s full-year 2026 EPS guidance stands at $4.70 to $4.80, and one cited consensus price target sits near $224, well above the current trading price; that target is third-party analyst opinion, not a guarantee. Institutional interest has ticked up regardless: hedge fund ownership tracked by Insider Monkey’s 13F-based database rose to 65 funds holding a combined $1.5 billion in BWXT as of the end of Q2 2026, up from 61 funds and roughly $1.36 billion the prior quarter.
None of this makes BWXT a speculative microcap; it is an established, decades-old nuclear services and components supplier with commercial operations across four continents. The open question flagged by multiple analysts is simply how much near-term earnings impact this specific win carries, given a construction start still more than two years out and four other vendors racing toward their own base deployments in the meantime.
BWXT: What to Watch
Site characterization, licensing, and design work for the Fort Campbell BANR begin immediately; construction is targeted for late 2028, with the reactor expected to be operational in the early 2030s.
Whether Tata Chemicals Soda Ash’s non-binding letter of intent for up to eight BANR units converts into a definitive commercial order remains unresolved.
BWXT’s full-year 2026 EPS guidance stands at $4.70 to $4.80 per share; the next quarterly report will show whether management attaches any near-term financial detail to the Janus award.
Sources
- Defense One: Army Selects 5 Companies to Build Nuclear Microreactors on Bases, Under New $2 Billion Deal, August 26, 2026
- StockTitan (BWXT press release): U.S. Army Chooses BWXT Advanced Nuclear Reactor (BANR) for Janus Program, August 26, 2026
- WSMV: Fort Campbell Included on List of Military Bases to Receive Advanced Nuclear Microreactor, August 27, 2026
- Simply Wall St: BWX Technologies (NYSE:BWXT) Stock Analysis, August 28, 2026
- Insider Monkey: BWXT’s Microreactor Bet Gets a Major Vote of Confidence from the U.S. Army, August 28, 2026
- Ad Hoc News: BWXT Stock Inches Higher as Army Microreactor Win Supports 2026 Earnings Outlook, August 29, 2026
Editorial Disclosure
This article is based entirely on publicly available information including government agency statements, named wire-service/company press releases, and named financial data sources. The only security discussed is BWX Technologies, Inc. (NYSE: BWXT). aktiego.com has not received any compensation from any company, IR firm, or third party mentioned. No staff member or principal of aktiego.com holds a position in any security mentioned at the time of publication. BWXT is a large, established company, not a small or micro-cap; it was selected this week because the underlying story, the Army’s first Janus Program microreactor deployment award, was significant, well-documented across multiple independent sources, and had no comparable small or micro-cap alternative in this coverage window, consistent with this chat’s standard of running one strong story rather than padding with weaker ones. The $2.2 billion Janus Program figure is the combined potential value across all five selected companies and bases, not a commitment to BWXT alone, and this article does not imply otherwise. The Tata Chemicals Soda Ash letter of intent is explicitly non-binding and is not a signed commercial order; it is discussed here as an exploratory step only. The cited consensus price target and EPS guidance are forward-looking figures; the price target is third-party analyst opinion, not aktiego.com’s own view, and guidance is a company projection, not a guarantee. Construction on the Fort Campbell reactor is not targeted to begin until late 2028, with operation expected in the early 2030s, meaning near-term financial impact to BWXT from this specific award is genuinely uncertain, a point several cited sources make explicitly. BWXT carries risk of capital loss like any publicly traded security. Coverage on aktiego.com is provided for informational and educational purposes only. aktiego.com is not a registered investment advisor. Nothing in this article constitutes financial, investment, or professional advice. Readers are encouraged to conduct their own due diligence and consult a qualified financial advisor before making any investment decisions. For more information please see our full DISCLAIMER.
